PHARM.ASPHARM.ASAMS
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank57
3Y CAGR-43.7%
5Y CAGR-34.4%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-43.7%/yr
Annual compound
5Y CAGR
-34.4%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.59% | +14.1% |
| 2023 | 4.03% | -75.3% |
| 2022 | 16.31% | -36.5% |
| 2021 | 25.69% | -36.3% |
| 2020 | 40.33% | +6.9% |
| 2019 | 37.74% | +14.4% |
| 2018 | 32.98% | +189.1% |
| 2017 | -37.03% | +55.4% |
| 2016 | -83.12% | +33.3% |
| 2015 | -124.58% | - |